BACKGROUND: The binge-drinking model in rodents using intragastric injections of ethanol (EtOH) for 4 days results in argyrophilic corticolimbic tissue classically interpreted as indicating irreversible neuronal degeneration. However, recent findings suggest that acquired argyrophilia can also identify injured neurons that have the potential to recover. The current in vivo magnetic resonance (MR) imaging and spectroscopy study was conducted to test the hypothesis that binge EtOH exposure would injure but not cause the death of neurons as previously ascertained postmortem. METHODS: After baseline MR scanning, 11 of 19 rats received a loading dose of 5 g/kg EtOH via oral gavage, then a maximum of 3 g/kg every 8 hours for 4 days, for a total average cumulative EtOH dose of 43 +/- 1.2 g/kg and average blood alcohol levels of 258 +/- 12 mg/dL. All animals were scanned after 4 days of gavage (post-gavage scan) with EtOH (EtOH group) or dextrose (control [Con] group) and again after 7 days of abstinence from EtOH (recovery scan). RESULTS: Tissue shrinkage at the post-gavage scan was reflected by significantly increased lateral ventricular volume in the EtOH group compared with the Con group. At the post-gavage scan, the EtOH group had lower dorsal hippocampal N-acetylaspartate and total creatine and higher choline-containing compounds than the Con group. At the recovery scan, neither ventricular volume nor metabolite levels differentiated the groups. CONCLUSIONS: Rapid recovery of ventricular volume and metabolite levels with removal of the causative agent argues for transient rather than permanent effects of a single EtOH binge episode in rats. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
BACKGROUND: The binge-drinking model in rodents using intragastric injections of ethanol (EtOH) for 4 days results in argyrophilic corticolimbic tissue classically interpreted as indicating irreversible neuronal degeneration. However, recent findings suggest that acquired argyrophilia can also identify injured neurons that have the potential to recover. The current in vivo magnetic resonance (MR) imaging and spectroscopy study was conducted to test the hypothesis that binge EtOH exposure would injure but not cause the death of neurons as previously ascertained postmortem. METHODS: After baseline MR scanning, 11 of 19 rats received a loading dose of 5 g/kg EtOH via oral gavage, then a maximum of 3 g/kg every 8 hours for 4 days, for a total average cumulative EtOH dose of 43 +/- 1.2 g/kg and average blood alcohol levels of 258 +/- 12 mg/dL. All animals were scanned after 4 days of gavage (post-gavage scan) with EtOH (EtOH group) or dextrose (control [Con] group) and again after 7 days of abstinence from EtOH (recovery scan). RESULTS: Tissue shrinkage at the post-gavage scan was reflected by significantly increased lateral ventricular volume in the EtOH group compared with the Con group. At the post-gavage scan, the EtOH group had lower dorsal hippocampal N-acetylaspartate and total creatine and higher choline-containing compounds than the Con group. At the recovery scan, neither ventricular volume nor metabolite levels differentiated the groups. CONCLUSIONS: Rapid recovery of ventricular volume and metabolite levels with removal of the causative agent argues for transient rather than permanent effects of a single EtOH binge episode in rats. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Authors: José Javier Miguel-Hidalgo; Jinrong Wei; Michael Andrew; James C Overholser; George Jurjus; Craig A Stockmeier; Grazyna Rajkowska Journal: Biol Psychiatry Date: 2002-12-15 Impact factor: 13.382
Authors: D J Meyerhoff; R Blumenfeld; D Truran; J Lindgren; D Flenniken; V Cardenas; L L Chao; J Rothlind; C Studholme; M W Weiner Journal: Alcohol Clin Exp Res Date: 2004-04 Impact factor: 3.455
Authors: Vishwadeep Ahluwalia; James B Wade; F Gerard Moeller; Melanie B White; Ariel B Unser; Edith A Gavis; Richard K Sterling; R Todd Stravitz; Arun J Sanyal; Mohammad S Siddiqui; Puneet Puri; Velimir Luketic; Douglas M Heuman; Michael Fuchs; Scott Matherly; Jasmohan S Bajaj Journal: Liver Transpl Date: 2015-07-21 Impact factor: 5.799
Authors: Isabella R Grifasi; Scot E McIntosh; Rhiannon D Thomas; Donald T Lysle; Todd E Thiele; S Alex Marshall Journal: Neuroimmunomodulation Date: 2019-01-09 Impact factor: 2.492
Authors: Natalie M Zahr; Aran M Lenart; Joshua A Karpf; Keriann M Casey; Kilian M Pohl; Edith V Sullivan; Adolf Pfefferbaum Journal: Neuropharmacology Date: 2020-03-30 Impact factor: 5.250
Authors: Krista M Lisdahl; Rachel Thayer; Lindsay M Squeglia; Tim M McQueeny; Susan F Tapert Journal: Psychiatry Res Date: 2012-11-13 Impact factor: 3.222
Authors: Dayna M Hayes; Chelsea G Nickell; Kevin Y Chen; Justin A McClain; Megan M Heath; M Ayumi Deeny; Kimberly Nixon Journal: Neuropharmacology Date: 2018-01-31 Impact factor: 5.250